Mood disorders are a modern-day epidemic, with more than 50% of Australians set to experience depression and/or anxiety in their lifetime. With patients now mandated to live physically isolated lives and anxiety levels at an all-time high, we are likely to see an increase in mental health issues across the broader community in coming months. 

As Practitioners we now have access to a new tool to help support patients’ moods: a novel probiotic formulation that has been shown to influence the Gut-Brain-Immune Axis and beneficially affect emotional wellbeing, behaviour, and immunity.

This combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 6475 is clinically trialled, scientifically validated, safe and effective. Tune in for this exclusive, live-streamed online event to learn more about this new formula!